Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid.

Virology
Jiong Shi, Christopher Aiken

Abstract

HIV-1 infection is restricted at a post-entry stage in some simian cell lines by species-specific variants of TRIM5 alpha. Restriction targets the viral capsid protein (CA) and results in attenuated reverse transcription. TRIM5 alpha restriction can be inhibited by the addition of noninfectious virus-like particles (VLPs), thus rendering cells permissive for infection by an HIV-1 reporter virus. Through the use of HIV-1 VLPs containing Gag cleavage site substitutions and point mutations in CA which alter the stability of the viral capsid, we demonstrate that saturation of TRIM5 alpha restriction depends on the stability of the capsid in the incoming VLPs. Differences in the requirement for cleavage of the specific sites in Gag were observed between distinct African green monkey cell lines. The results strongly suggest that the mechanism of HIV-1 restriction by TRIM5 alpha involves engagement of the viral capsid by the restriction factor prior to completion of uncoating.

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R L WilleyM A Martin
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·P GallayD Trono
Aug 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Simone CowanPaul D Bieniasz
Aug 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Caroline BesnierGreg Towers
Jan 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Neeltje A KootstraInder M Verma
Jan 30, 2003·The EMBO Journal·Theodora HatziioannouGreg J Towers
Apr 15, 2003·Journal of Virology·Uta K von SchwedlerWesley I Sundquist
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Theodora HatziioannouPaul D Bieniasz
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zuzana KeckesovaGreg J Towers
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Melvyn W YapJonathan P Stoye
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sébastien NisoleMelvyn W Yap
Jan 15, 2005·Current Biology : CB·Melvyn W YapJonathan P Stoye
Mar 16, 2005·Journal of Virology·Byeongwoon SongJoseph Sodroski
May 11, 2005·Virology·Prasert AuewarakulPilaipan Puthavathana
Jul 30, 2005·Journal of Virology·Mark P DoddingJonathan P Stoye
Oct 29, 2005·Journal of Virology·Claudia C MischeJoseph Sodroski

❮ Previous
Next ❯

Citations

Sep 26, 2007·Retrovirology·Julie BérubéLionel Berthoux
May 24, 2008·PLoS Pathogens·Christopher James Rold, Christopher Aiken
Sep 19, 2008·Journal of Virology·Alak Kanti KarJoseph Sodroski
Sep 22, 2009·PloS One·Silke SchüleMatthias Schweizer
Mar 12, 2010·Journal of Virology·Marisa S BrionesSamson A Chow
Apr 23, 2010·Journal of Virology·Lesa R Black, Christopher Aiken
Apr 2, 2011·PLoS Pathogens·Gongpu ZhaoPeijun Zhang
Apr 15, 2011·PLoS Pathogens·Gloria ArriagadaStephen P Goff
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Amy E HulmeThomas J Hope
Aug 19, 2011·AIDS Research and Human Retroviruses·Abdul A Waheed, Eric O Freed
Feb 25, 2009·Immunogenetics·Welkin E Johnson, Sara L Sawyer
Aug 20, 2010·Immunologic Research·Marisa S Briones, Samson A Chow
Sep 29, 2009·Antiviral Research·Catherine S Adamson, Eric O Freed
Sep 24, 2015·AIDS Research and Human Retroviruses·Junxiao DengHuanzhang Zhu
Oct 20, 2010·Virology·Beatriz PachecoJoseph Sodroski
Jun 17, 2015·Human Gene Therapy·Ulrike JungLionel Berthoux
Jan 8, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sonia Gauthier, Michel J Tremblay
Aug 31, 2013·PLoS Pathogens·Fan WuVanessa M Hirsch
Sep 8, 2012·PLoS Pathogens·Amanda J PriceLeo C James
Jul 12, 2016·PLoS Pathogens·David F BoydJulie Overbaugh
Dec 6, 2016·Nature·Carla M S RibeiroTeunis B H Geijtenbeek
Aug 28, 2020·The EMBO Journal·Rebecca P SumnerGreg J Towers
Aug 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·João I MamedeThomas J Hope
Jun 30, 2019·International Journal of Molecular Sciences·Vivian K Rojas, In-Woo Park

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.